Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ryvlin

Showing results (261-270 of 316) with videos related to

Pageof 32
Sort By:
Epilepsy Currents|July 8, 2017
Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyCynthia Harden, Torbjörn Tomson, David Gloss, et al.
Journal of Sleep Research|September 22, 2020
Standard procedures for the diagnostic pathway of sleep-related epilepsies and comorbid sleep disorders: A European Academy of Neurology, European Sleep Research Society and International League against Epilepsy-Europe consensus reviewLino Nobili, Al de Weerd, Guido Rubboli, et al.
Epilepsy & Behavior : E&B|May 29, 2012
Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrenceAndres M Kanner, Steven C Schachter, John J Barry, et al.
Epilepsy & Behavior : E&B|May 29, 2012
Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectivesAndres M Kanner, Steven C Schachter, John J Barry, et al.
The Journal of Headache and Pain|December 19, 2022
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim resultsAndreas R Gantenbein, Reto Agosti, Christian P Kamm, et al.
Journal of Neurology|June 13, 2024
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim resultsAndreas R Gantenbein, Christophe Bonvin, Christian P Kamm, et al.
Neurology|April 26, 2017
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyCynthia Harden, Torbjörn Tomson, David Gloss, et al.
Epilepsia|September 23, 2025
Artificial intelligence-driven closed-loop devices in sudden unexpected death in epilepsy prediction and prevention: Insights from persons with epilepsy and caregiversJoão Ferreira, Miguel França, Mariana Cardoso Regalo, et al.
The Journal of Headache and Pain|November 19, 2022
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim resultsAndreas R Gantenbein, Reto Agosti, Christian P Kamm, et al.
Epilepsia|August 9, 2020
Big data in epilepsy: Clinical and research considerations. Report from the Epilepsy Big Data Task Force of the International League Against EpilepsySamden D Lhatoo, Neda Bernasconi, Ingmar Blumcke, et al.
Pageof 32

Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
Epilepsy Currents|July 8, 2017
Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyCynthia Harden, Torbjörn Tomson, David Gloss, et al.
Journal of Sleep Research|September 22, 2020
Standard procedures for the diagnostic pathway of sleep-related epilepsies and comorbid sleep disorders: A European Academy of Neurology, European Sleep Research Society and International League against Epilepsy-Europe consensus reviewLino Nobili, Al de Weerd, Guido Rubboli, et al.
Epilepsy & Behavior : E&B|May 29, 2012
Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrenceAndres M Kanner, Steven C Schachter, John J Barry, et al.
Epilepsy & Behavior : E&B|May 29, 2012
Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectivesAndres M Kanner, Steven C Schachter, John J Barry, et al.
The Journal of Headache and Pain|December 19, 2022
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim resultsAndreas R Gantenbein, Reto Agosti, Christian P Kamm, et al.
Journal of Neurology|June 13, 2024
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim resultsAndreas R Gantenbein, Christophe Bonvin, Christian P Kamm, et al.
Neurology|April 26, 2017
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyCynthia Harden, Torbjörn Tomson, David Gloss, et al.
Epilepsia|September 23, 2025
Artificial intelligence-driven closed-loop devices in sudden unexpected death in epilepsy prediction and prevention: Insights from persons with epilepsy and caregiversJoão Ferreira, Miguel França, Mariana Cardoso Regalo, et al.
The Journal of Headache and Pain|November 19, 2022
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim resultsAndreas R Gantenbein, Reto Agosti, Christian P Kamm, et al.
Epilepsia|August 9, 2020
Big data in epilepsy: Clinical and research considerations. Report from the Epilepsy Big Data Task Force of the International League Against EpilepsySamden D Lhatoo, Neda Bernasconi, Ingmar Blumcke, et al.
Pageof 32